PHENDIMETRAZINE TARTRATE
PHENDIMETRAZINE TARTRATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PHENDIMETRAZINE TARTRATE; Generic name: PHENDIMETRAZINE TARTRATE; Manufacturer: Acertis Pharmaceuticals, LLC.
| Brand name | PHENDIMETRAZINE TARTRATE |
|---|---|
| Generic name | PHENDIMETRAZINE TARTRATE |
| Manufacturer | Acertis Pharmaceuticals, LLC |
| Used for | INDICATIONS AND USAGE Phendimetrazine tartrate extended-release capsules are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of greater than or equal to 30 kg/m 2 or greater than or equal to 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia) who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by |
| Dosage | DOSAGE AND ADMINISTRATION Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal). Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254. |
| Warnings | WARNINGS Phendimetrazine tartrate should not be used in combination with other anorectic agents, including prescribed drugs, over-the-counter preparations and herbal products. In a case-control epidemiological study, the use of anorectic agents, including phendimetrazine tartrate, was associated with an increased risk of developing pulmonary hypertension, a rare, but often fatal disorder. The use of anorectic agents for longer than three months was associated with a 23-fold increase in the risk |
| Active ingredient(s) | PHENDIMETRAZINE TARTRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=162140d3-b833-4633-9759-95821a46a690 |